US 11,654,099 B2
Producing a topical solution composition
Kay Liu, San Marino, CA (US)
Assigned to Shantel Medical Supply Corp., Arcadia, CA (US)
Filed by Shantel Medical Supply Corp., Arcadia, CA (US)
Filed on Aug. 19, 2020, as Appl. No. 16/997,121.
Application 16/997,121 is a continuation of application No. 15/715,037, filed on Sep. 25, 2017, granted, now 10,888,515.
Application 15/715,037 is a continuation in part of application No. 15/685,687, filed on Aug. 24, 2017, abandoned.
Application 15/685,687 is a continuation of application No. 11/837,735, filed on Aug. 13, 2007, granted, now 9,770,480, issued on Sep. 26, 2017.
Prior Publication US 2021/0030662 A1, Feb. 4, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 8/96 (2006.01); A61K 8/67 (2006.01); A61K 8/06 (2006.01); A61Q 19/02 (2006.01); A61K 8/34 (2006.01); A61K 8/9789 (2017.01)
CPC A61K 8/96 (2013.01) [A61K 8/06 (2013.01); A61K 8/347 (2013.01); A61K 8/673 (2013.01); A61K 8/678 (2013.01); A61K 8/9789 (2017.08); A61Q 19/02 (2013.01); A61K 2800/85 (2013.01)] 27 Claims
 
1. A topical solution composition comprising:
a red wine extract present in an amount ranging from 1.0 to 50.0 weight percent based on a total weight of the topical solution composition, the red wine extract comprising resveratrol;
water;
an emulsifier;
vitamins, wherein the vitamins are present in the topical solution composition in an amount that is sufficient to provide the topical solution composition with a pH ranging from 2.5 to 4.5;
wherein the topical solution composition is in the form of a topical gel or a topical cream; and
wherein the topical solution composition exhibits the capability of reducing the number of visible lesions on human skin by from 10% to 50%.